Supplementary Table S2 from Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma During Targeted Therapy
crossref（2024）
摘要
Supplementary Table S2. VAFs detected by the iCCA panel using commercial references (0.5% SeraSeq and 1% SeraSeq) at different coverage depths.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要